References
- 1. CHANDRASHEKAR A, RAMAKRISHNAN S, RANGARJAN D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014; 24(4):206-13. doi: 10.4103/0971-4065.132985.
- 2. SCHOLZE A, RATTENSPERGER D, ZIDEK W, TEPEL M. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity 2007; 15(6): 1617–22. doi: 10.1038/oby.2007.191.
- 3. SAMEIRO-FARIA MD, RIBEIRO S, COSTA E, MENDONCA D, TEXEIRA L et al. Risk factors for mortality in hemodialysis patients: two-year follow-up study. Dis Markers. 2013;35(6):791–8. Do i: 10.1155/2013/518945.
- 4. PALMER SC,RUOSPO M, CAMPBELL KL, GARCIA ALERSEN V, SAGLIMBENE V et al. Nutrition and dietary, intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD,a prospective multinational cohort study. BMJ Open 2015;5:e006897.doi:10.1136/bmjopen-2014-006897.
- 5. RISOVIĆ I, VLATKOVIĆ V, POPOVIĆ-PEJIČIĆ S, TRBOJEVIĆ-STANKOVIĆ J. The relationship between leptin level, inflammation and volume status in maintenance hemodialysis patient. Ther Apher Dial 2019; 23(1):59–64. doi: 10.1111/1744-9987.12750.
- 6. ACHINGER SG, AYUS JC. Inflammation from dialysis, can it be removed? Nephrol Dial Transplant 2013; 28 (4): 770–3. doi: 10.1093/ndt/gfs480.
- 7. BROOKHART MA, SSHNEEWEISS S, AVORN J, BRADBURY BD, LIU J, WINKELMAYER WC. Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients. JAMA. 2010; 303(9):857–64. doi:10.1001/jama.2010.206.
- 8. KDIGO clinical pracitice guideline for Anemia in Chronic Kidney Disease. Kidney Int 2012; 2:279–335.
- 9. FULLER DS, DLUZNIEWSKI PJ, COOPER K, BRADBURY BD, ROBINSON BM,TENTORI F. Combinations of mineral and bone disorder markers and risk of death and hospitalizations in the international Dialysis Outcomes and Practice Patterns Study, Clin Kidney J, sfz112, doi: 10.1093/ckj/sfz112.
- 10. KELESIDIS T, KELESIDIS I, CHOU S, MANTZOROS C. Narrative review: the role of leptin in human physiology:emerging clinical applications. Ann Intern Med 2010; 152(2):93–100. doi:10.1059/0003-4819-152-2-201001190-0000.
- 11. FRIEDMAN J. Leptin at 20: an overiew. J Endocrinol 2014; 223:1–8. doi. 10.1530/JOE-14-0405.
- 12. PARK HY, AHIMA RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 2015; 64(1):24–6. doi: 10.1016/j.metabol.2014.08.004.
- 13. BUENO DE OLIVERA R, LIABEUF S, OKAZAKI H, LENGLET A, DESJARDINSZ L et al. The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients. Clin Kidney J 2013; 6: 63–70. doi: 10.1093/ckj/sfs176
- 14. MA L, ZHAO S. Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis. Int J Cardiol. 2017; 238:151–58. doi:10.1016/j.ijcard.2017.02.095
- 15. KURAGANO T, MATSUMURA O, MATSUDA A, HARA T, KIYOMOTO H et al. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. Kidney Int. 2014; 86: 845–54 doi: 10.1038/ki.2014.114
- 16. ANTALAGER M, HECKING M, HALDINGER M, WERZOWA J, KOVARIK JJ et al. Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status. BMC Nephrol 2013;2:266 doi: 10.1186/1471-2369-14-266
- 17. KALANTAR-ZADEH K, IKLIZER TA, BLOCK G, AVRAM MM, KOPPLE JD. Malnutrition inflammation complex syndome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 4(5); 864–8. doi: 10.1016/j.ajkd.2003.07.016
- 18. WAZIRI B, DUARTE R, NAICKER S. Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives. Int J Nephrol Renovasc Dis. 2019. 24; 12:263–76. doi: 10.2147/IJNRD.S191156.
- 19. DON BR, KAYSEN G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004; 17:432–7. doi: 10.1111/j.0894-0959.2004.17603.x.
- 20. SRIDHAR NR, JOSULA S. Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study. BMC Nephrol. 2013; 14:242–49. doi:10.1186/1471-2369-14-242
- 21. AHAMADI F, BOSOSRGEMEHR R, RAZEGHI E. Relationship between serum leptin level and laboratory and anthropometric indices of malnutrition in patients on hemodialysis. Indian J Nephrol 2008;18 (3): 105–11 doi: 10.4103/0971-4065.43689
- 22. YILMAZ A, KAYARDI M, ICOGASIOGLU S, CANDAN F, NUR N, GULTEKIN F. Relationship between serum leptin levels and body composition and markers of malnutrition in nondiabetic patients on peritoneal dialysis or hemodialysis. J Chin Med Assoc. 2005; 68:566–70. doi: 10.1016/s1726-4901(09)70095-4.
- 23. KALANTAR-ZADEH K; ABOTT KC, SALAHUDEEN AK, KILPATRIC RD, HORWICH TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543–84. doi: 10.1093/ajcn/81.3.543
- 24. KALANTAR-ZADEH K,STREJA E, MOLNAR MZ, LUKOWSKY LR, KRISHNAN M et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol. 2012; 175(8):793–803. doi 10.1093/aje/kwr384
- 25. BIAN X, LIU N, BAI Y, ZHENG L, HE P et al. Association of leptin with mortality in patients on maintenance hemodialysis IJKD 2014;8(4):314–20. PMID: 25001138.